Perrigo | PRGO - Ordinary Share Capital


Perrigo reported $137.6M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Abbott USD 1.74B 23.39B Sep/2025
Bayer EUR 982.42M 0 Dec/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Coherus Biosciences USD 121.16M 4.92M Dec/2025
Corcept Therapeutics USD 105.97M 842K Dec/2025
Dr.Reddys Laboratories INR 832.52M 144K Sep/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
J&J USD 2.41B 1.74M Dec/2025
Merck USD 2.49B 15.79M Sep/2025
Nestle CHF 2.57B 42.99M Dec/2025
Pacira USD 41.12M 1.85M Dec/2025
Perrigo USD 137.6M 0 Dec/2025
Pfizer USD 5.69B 1000K Sep/2025
Phibro Animal Health USD 40.48M 0 Dec/2025
Prestige Brands USD 48.08M 47.52M Sep/2025
Reckitt Benckiser GBP 679.21M 605.21M Jun/2025
Sanofi EUR 1.21B 8.25M Mar/2026
Supernus Pharmaceuticals USD 57.12M 1000K Sep/2025
Teva Pharmaceutical Industries USD 1.15B 0 Dec/2025
Xeris Pharmaceuticals USD 166.22M 687.16K Dec/2025
Zoetis USD 424.93M 16.54M Dec/2025